ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
154.73%
Change (1 year)
Categories
Earnings for ImmunoGen (IMGN)
Earnings in 2023 (TTM): -$62.78 M
According to ImmunoGen 's latest financial reports the company's current earnings (TTM) are -$62.78 M. In 2022 the company made an earning of -$0.22 B a decrease over its 2021 earnings that were of -$0.13 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ImmunoGen from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$62.78 M | -71.14% |
| 2022 | -$0.22 B | 72.45% |
| 2021 | -$0.13 B | 495.9% |
| 2020 | -$21.17 M | -75.71% |
| 2019 | -$87.16 M | -44.88% |
| 2018 | -$0.16 B | 99.42% |
| 2017 | -$79.29 M | |
| 2015 | -$0.11 B | 43.7% |
| 2014 | -$72.6 M | 135.39% |
| 2013 | -$30.84 M | -66.03% |
| 2012 | -$90.78 M | 42.86% |
| 2011 | -$63.54 M | 16.68% |
| 2010 | -$54.46 M | 32.83% |
| 2009 | -$41 M | -1.99% |
| 2008 | -$41.84 M | 108.61% |
| 2007 | -$20.06 M | -10.13% |
| 2006 | -$22.32 M | 28.86% |
| 2005 | -$17.32 M | 120.33% |
| 2004 | -$7.86 M | -61.19% |
| 2003 | -$20.25 M | -16.6% |
| 2002 | -$24.28 M | 51.86% |
| 2001 | -$15.99 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -27,134.52% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -15,753.32% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | -5,303.97% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -10,540.75% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -12,612.15% | 🇺🇸 USA |
 Sanofi SNY | $8.39 B | -13,472.85% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | -$5.85 B | 9,212.03% | 🇺🇸 USA |
 Seagen
SGEN | -$0.8 B | 1,159.30% | 🇺🇸 USA |